% Expired Patents = 33.3

EPO Patents = 1

Forward Citations = 6

Loading Chart...

10 inventors (with patents filed for the assignee):

Haiching Ma (4 out of 5 patents)

Yangbo Feng (3 out of 3 patents)

Yuren Wang (2 out of 2 patents)

4. Sung Ok Yoon (2 out of 2 patents)

5. Jeffrey R Peterson (1 out of 1 patent)

6. Sean Deacon (1 out of 1 patent)

7. Sorin Vasile Filip (1 out of 1 patent)

8. Matthew Alexander Henry (1 out of 1 patent)

9. James Alexander Dolan (1 out of 1 patent)

10. Bartosz Dietrich (1 out of 1 patent)

6 patents: Sort by Forward Citations

1. 12747234 - Kinase inhibitors for the treatment of neurodegenerative diseases (2026-09-29),

2. 12448375 - Kinase inhibitors for the treatment of neurodegenerative diseases (2025-10-21),

3. 11155550 - Histone deacetylase inhibitors and methods of use thereof (2021-10-26),

4. 10011611 - Histone deacetylase inhibitors and methods for use thereof (2018-07-03),

5. 8658655 - Inhibition of activated cdc42-associated kinase 1 (2014-02-25),

6. 8592415 - Selective kinase inhibitors (2013-11-26),

Company Overview

Reaction Biology Corporation is a leading provider of high-quality biochemical enzyme assays for drug discovery and development. With expertise in kinase, epigenetic, and other enzyme assays, RBC offers comprehensive screening solutions to pharmaceutical and biotech companies worldwide. With a focus on accelerating the drug discovery process, RBC provides innovative technologies and services to support research in areas such as oncology, neurology, and cardiovascular disease.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

6 Patents

#49 in Malvern, PA

#1,623 in Pennsylvania

#44,981 in US

Malvern, PA, United States of America

Reaction Biology Corporation

Forward Citations = 6

10 inventors:

Haiching Ma (4 out of 5 patents)

Yangbo Feng (3 out of 3 patents)

Yuren Wang (2 out of 2 patents)

4. Sung Ok Yoon (2 out of 2 patents)

5. Jeffrey R Peterson (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Reaction Biology Corporation. Retrieved from https://idiyas.com/company/reaction-biology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]